Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Change in Acquisitions & Divestments: 2020-2025

Historic Change in Acquisitions & Divestments for BridgeBio Pharma (BBIO) over the last 4 years, with Sep 2025 value amounting to $8.0 million.

  • BridgeBio Pharma's Change in Acquisitions & Divestments fell 74.82% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.0 million, marking a year-over-year decrease of 5.40%. This contributed to the annual value of $95.0 million for FY2024, which is 14.07% down from last year.
  • As of Q3 2025, BridgeBio Pharma's Change in Acquisitions & Divestments stood at $8.0 million, which was down 74.82% from $31.8 million recorded in Q3 2024.
  • In the past 5 years, BridgeBio Pharma's Change in Acquisitions & Divestments ranged from a high of $186.7 million in Q1 2022 and a low of $8.0 million during Q3 2025.
  • In the last 3 years, BridgeBio Pharma's Change in Acquisitions & Divestments had a median value of $28.0 million in 2023 and averaged $30.5 million.
  • Per our database at Business Quant, BridgeBio Pharma's Change in Acquisitions & Divestments surged by 249.20% in 2021 and then crashed by 90.26% in 2023.
  • Over the past 5 years, BridgeBio Pharma's Change in Acquisitions & Divestments (Quarterly) stood at $75.0 million in 2021, then plummeted by 64.17% to $26.9 million in 2022, then grew by 4.23% to $28.0 million in 2023, then soared by 105.21% to $31.8 million in 2024, then tumbled by 74.82% to $8.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $8.0 million in Q3 2025, compared to $31.8 million in Q3 2024 and $63.2 million in Q1 2024.